- News & Analysis
Page 593
Quanterix tracks route to IPO
Quanterix, a digital immunoassay developer spun out of Tufts University, has raised $64.1m in its initial public offering.
Dec 7, 2017Medlinker makes $60m appointment with corporate investors
China Electronics Corporation Data led the doctor-focused social media app's latest round, which included existing investor Tencent.
Dec 7, 2017Corporates pay for a piece of Obsidian
Alphabet, Takeda, ShangPharma and Amgen were among the investors in gene and cell therapy startup Obsidian Therapeutics' $49.5m series A round.
Dec 7, 2017Quanterix tracks route to IPO
Quanterix, a digital immunoassay developer backed by BioMerieux and Stratec, has raised $64.1m in its initial public offering.
Dec 7, 2017Fusion Antibodies amps up for IPO
Queen's University spinout Fusion Antibodies is targeting $7.4m in proceeds in an IPO that will provide an exit to Qubis and Invest NI.
Dec 7, 2017LivaNova imbibes ImThera in $225m deal
LivaNova will pay $78m up front to acquire sleep apnoea device maker and portfolio company ImThera Medical in a deal that could reach $225m.
Dec 6, 2017Mytonomy mines corporates for $7m
Mytonomy, the developer of a patient education platform for hospitals, has raised money in a series A round backed by Philips and MedStar Health.
Dec 5, 2017BioHub Birmingham to add lab space
The university-owned incubator is set to expand next year, after the ground floor reached capacity while demand for space has continued.
Dec 5, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
© 2026 Mawsonia Ltd. All rights reserved.test regLogin